Research Capital analyst André Uddin delivered an update to clients on Friday on HIV-specializing Theratechnologies (Theratechnologies Stock Quote, Charts, News, Analysts, Financials NASDAQ:THTX), saying investors are now waiting for TH to get the green light from the FDA to restart one of its clinical trials. A combined specialty pharma and biotechnology company, Montreal-based Theratechnologies announced […]
Echelon Capital Markets analyst Stefan Quenneville continues to like Valeo Pharma (Valeo Pharma Stock Quote, Charts, News, Analysts, Financials TSX:VPH), saying the specialty pharma company will show strong operating leverage as it commercializes its portfolio of assets. Quenneville maintained a “Speculative Buy” rating in a Thursday update and $1.00 target price, which at press time […]
Share
Tweet
Share
